Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -715,075 | -361,918 | -50,688 | -267,265 | -220,030 |
| Depreciation Amortization | 24,500 | 4,573 | 7,204 | 5,691 | 5,899 |
| Accounts receivable | -41,835 | -19,576 | -24,240 | -1,251 | -1,561 |
| Other Working Capital | -66,881 | -107,892 | -97,461 | -15,767 | 31,985 |
| Other Operating Activity | 342,828 | 96,153 | -66,811 | 32,772 | 34,242 |
| Operating Cash Flow | $-456,463 | $-388,660 | $-231,996 | $-245,820 | $-149,465 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 521,994 | -305,790 | -293,295 | -83,327 | 23,938 |
| PPE Investments | -59,631 | -61,157 | -12,000 | -5,341 | -3,401 |
| Net Acquisitions | -172,556 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -10,695 |
| Sale Of Investment | N/A | N/A | 10,695 | 0 | 0 |
| Purchase Sale Intangibles | N/A | 0 | 115,785 | -1,525 | -1,432 |
| Other Investing Activity | -3,082 | -3,541 | 115,785 | -1,525 | -1,432 |
| Investing Cash Flow | $286,725 | $-370,488 | $-178,815 | $-90,193 | $8,410 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 245,625 | 235,872 | 69,708 | 0 | 20,000 |
| Debt Repayment | N/A | -267,219 | -54,754 | -7,603 | -2,598 |
| Common Stock Issued | 401,955 | 563,631 | 369,183 | 385,732 | 130,805 |
| Other Financing Activity | -5,026 | -2,134 | 503,945 | 0 | -399 |
| Financing Cash Flow | $642,554 | $530,150 | $888,082 | $378,129 | $147,808 |
| Beginning Cash Position | 370,829 | 599,827 | 122,556 | 80,440 | 73,687 |
| End Cash Position | 843,645 | 370,829 | 599,827 | 122,556 | 80,440 |
| Net Cash Flow | $472,816 | $-228,998 | $477,271 | $42,116 | $6,753 |
| Free Cash Flow | |||||
| Operating Cash Flow | -456,463 | -388,660 | -231,996 | -245,820 | -149,465 |
| Capital Expenditure | -59,631 | -61,157 | -12,000 | -5,341 | -3,401 |
| Free Cash Flow | -516,094 | -449,817 | -243,996 | -251,161 | -152,866 |